{"id":"NCT00240331","sponsor":"AstraZeneca","briefTitle":"AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)","officialTitle":"A Study to Evaluate the Use of Rosuvastatin in Subjects On Regular Haemodialysis: an Assessment of Survival and Cardiovascular Events (AURORA). A Double Blind, Randomised, Phase 3b, Parallel-group Study to Compare the Effects of Rosuvastatin With Placebo on Assessment of Survival & Cardiovascular Events When Given to Subjects With End-stage Renal Failure on Chronic Haemodialysis Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-01","primaryCompletion":"2008-10","completion":"2008-10","firstPosted":"2005-10-18","resultsPosted":"2009-11-04","lastUpdate":"2011-05-19"},"enrollment":2776,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Renal Failure"],"interventions":[{"type":"DRUG","name":"10mg Rosuvastatin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Rosuvastatin 10mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to see if rosuvastatin helps to reduce the number of heart attacks, strokes and cardiovascular deaths in patients undergoing haemodialysis.","primaryOutcome":{"measure":"Number of Randomised Participants With a Major Cardiovascular Event (Non-fatal Stroke, Non-fatal Myocardial Infarction or Cardiovascular Death)","timeFrame":"Events were reported continuously during the study. Duration of follow-up ranged from 1 day to 5.6 years","effectByArm":[{"arm":"Rosuvastatin 10mg","deltaMin":396,"sd":null},{"arm":"Placebo","deltaMin":408,"sd":null}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":239,"countries":["Australia","Austria","Belgium","Brazil","Bulgaria","Canada","Czechia","Denmark","Finland","France","Germany","Greece","Hungary","Iceland","Ireland","Italy","Mexico","Netherlands","Norway","Poland","South Korea","Sweden","Switzerland","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["19332456"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1140},"commonTop":["Diarrhoea","Bronchitis","Arteriovenous Fistula Site Complication","Cough","Nasopharyngitis"]}}